Evaluation of noninvasive exercise cardiac output determination in chronic heart failure patients: A proposal of a new diagnostic and prognostic method

Journal of Cardiovascular Medicine

Volumn 12, Issue 1, 2011, Pages 19-27

  Cattadori, Gaia ^a   Salvioni, Elisabetta ^a   Gondoni, Erica ^a   Agostoni, Piergiuseppe ^a,b,c  

^a Cardiologic Institute Monzino   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Cardiac output; Exercise; Heart failure; Inert gases

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS;

CARDIAC RESYNCHRONIZATION THERAPY; CARDIOPULMONARY EXERCISE TEST; CLINICAL ASSESSMENT; CLINICAL EVALUATION; DIAGNOSIS; GOLD STANDARD; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE OXYGEN CONSUMPTION; HEART OUTPUT; HEMODYNAMIC PARAMETERS; HUMAN; NON INVASIVE PROCEDURE; OXYGEN CONSUMPTION; PROGNOSIS; REVIEW;

CARDIAC OUTPUT; CHRONIC DISEASE; EXERCISE; EXERCISE TEST; HEART FAILURE; HUMANS; OXYGEN CONSUMPTION;

EID: 79953721927     PISSN: 15582027     EISSN: None     Source Type: Journal    
DOI: 10.2459/JCM.0b013e3283405c4c     Document Type: Review

References (55)

1. Weber KT, Janicki JS. Cardiopulmonary exercise testing for evaluation of chronic cardiac failure. Am J Cardiol 1985; 55:22A-31A.
2. Mancini DM, Eisen H, Kussmaul W, Mull R, Edmunds LH Jr, Wilson JR. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 1991; 83:778-786.
3. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, Shusterman NH. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med 1996; 334:1349-1355. (Pubitemid 26152713)
4. Colucci WS, Packer M, Bristow MR, Gilbert EM, Cohn JN, Fowler MB, et al. Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study Group. Circulation 1996; 94:2800-2806. (Pubitemid 26411744)
5. Packer M, Fowler MB, Roecker EB, Coats AJ, Katus HA, Krum H, et al. Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study. Circulation 2002; 106:2194-2199. (Pubitemid 35222212)
6. Lechat P, Hulot JS, Escolano S, Mallet A, Leizorovicz A, Werhlen- Grandjean M, et al. Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II Trial. Circulation 2001; 103:1428-1433. (Pubitemid 32220636)
7. Heidenreich PA, Lee TT, Massie BM. Effect of beta-blockade on mortality in patients with heart failure: a meta-analysis of randomized clinical trials. J Am Coll Cardiol 1997; 30:27-34. (Pubitemid 27357123)
8. Perego GB, Marenzi GC, Guazzi M, Sganzerla P, Assanelli E, Palermo P, et al. Contribution of PO2, P50, and Hb to changes in arteriovenous O2 content during exercise in heart failure. J Appl Physiol 1996; 80:623-631.
9. Wasserman K, Zhang YY, Gitt A, Belardinelli R, Koike A, Lubarsky L, Agostoni PG. Lung function and exercise gas exchange in chronic heart failure. Circulation 1997; 96:2221-2227. (Pubitemid 27425826)
10. Agostoni P, Wasserman K, Perego GB, Marenzi GC, Guazzi M, Assanelli E, et al. Oxygen transport to muscle during exercise in chronic congestive heart failure secondary to idiopathic dilated cardiomyopathy. Am J Cardiol 1997; 79:1120-1124. (Pubitemid 27217074)
11. Agostoni P, Wasserman K, Guazzi M, Cattadori G, Palermo P, Marenzi G, Guazzi MD. Exercise-induced hemoconcentration in heart failure due to dilated cardiomyopathy. Am J Cardiol 1999; 83:278-280; A6.
12. Agostoni P, Cerino M, Palermo P, Magini A, Bianchi M, Bussotti M, et al. Exercise capacity in patients with beta-thalassaemia intermedia. Br J Haematol 2005; 131:278-281. (Pubitemid 43899697)
13. Hunt SA. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 2005; 46:e1-e82.
14. Wasserman K, Sun XG, Hansen JE. Effect of biventricular pacing on the exercise pathophysiology of heart failure. Chest 2007; 132:250-261. (Pubitemid 47068229)
15. Auricchio A, Kloss M, Trautmann SI, Rodner S, Klein H. Exercise performance following cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. Am J Cardiol 2002; 89:198-203. (Pubitemid 34132910)
16. Cattadori G, Giraldi F, Berti M, Carbucicchio C, Pepi M, Della Bella P, et al. Assessment of cardiac resynchronization therapy response. Int J Cardiol 2009; 136:240-242.
17. Belardinelli R, Lacalaprice F, Carle F, Minnucci A, Cianci G, Perna G, D'Eusanio G. Exercise-induced myocardial ischaemia detected by cardiopulmonary exercise testing. Eur Heart J 2003; 24:1304-1313. (Pubitemid 36917701)
18. Wasserman K, Hansen J, Sue DY, Casaburi R, Whipp BJ. Clinical applications of cardiopulmonary exercise testing. In Wasserman K, Hansen JE, Sue DY, Casaburi R, Whipp BJ, editors. Principle of exercise testing and interpretation. 3rd ed. Philadelphia: Lippincott, Williams & Wilkins; 1999.
19. Williams SG, Cooke GA, Wright DJ, Parsons WJ, Riley RL, Marshall P, Tan LB. Peak exercise cardiac power output: a direct indicator of cardiac function strongly predictive of prognosis in chronic heart failure. Eur Heart J 2001; 22:1496-1503. (Pubitemid 32769177)
20. Cotter G, Williams SG, Vered Z, Tan LB. Role of cardiac power in heart failure. Curr Opin Cardiol 2003; 18:215-222. (Pubitemid 36960470)
21. Franciosa JA, Ziesche S, Wilen M. Functional capacity of patients with chronic left ventricular failure. Relationship of bicycle exercise performance to clinical and hemodynamic characterization. Am J Med 1979; 67:460-466. (Pubitemid 10237031)
22. Weber KT, Kinasewitz GT, Janicki JS, Fishman AP. Oxygen utilization and ventilation during exercise in patients with chronic cardiac failure. Circulation 1982; 65:1213-1223. (Pubitemid 12105109)
23. Gelberg HJ, Rubin SA, Ports TA, Brundage BH, Parmley WW, Chatterjee K. Detection of left ventricular functional reserve by supine exercise hemodynamics in patients with severe, chronic heart failure. Am J Cardiol 1979; 44:1062-1067. (Pubitemid 10205769)
24. Griffin BP, Shah PK, Ferguson J, Rubin SA. Incremental prognostic value of exercise hemodynamic variables in chronic congestive heart failure secondary to coronary artery disease or to dilated cardiomyopathy. Am J Cardiol 1991; 67:848-853.
25. Roul G, Moulichon ME, Bareiss P, Gries P, Koegler A, Sacrez J, et al. Prognostic factors of chronic heart failure in NYHA class II or III: value of invasive exercise haemodynamic data. Eur Heart J 1995; 16:1387-1398.
26. Chomsky DB, Lang CC, Rayos GH, Shyr Y, Yeoh TK, Pierson RN 3rd, et al. Hemodynamic exercise testing. A valuable tool in the selection of cardiac transplantation candidates. Circulation 1996; 94:3176-3183.
27. Metra M, Faggiano P, D'Aloia A, Nodari S, Gualeni A, Raccagni D, Dei Cas L. Use of cardiopulmonary exercise testing with hemodynamic monitoring in the prognostic assessment of ambulatory patients with chronic heart failure. J Am Coll Cardiol 1999; 33:943-950.
28. Myers J, Gullestad L, Vagelos R, Do D, Bellin D, Ross H, Fowler MB. Clinical, hemodynamic, and cardiopulmonary exercise test determinants of survival in patients referred for evaluation of heart failure. Ann Intern Med 1998; 129:286-293. (Pubitemid 28394573)
29. Leier CV, Patrick TJ, Hermiller J, Pacht KD, Huss P, Magorien RD, Unverferth DV. Nifedipine in congestive heart failure: effects on resting and exercise hemodynamics and regional blood flow. Am Heart J 1984; 108:1461-1468. (Pubitemid 15075898)
30. Agostoni PG, Wasserman K, Perego GB, Guazzi M, Cattadori G, Palermo P, et al. Noninvasive measurement of stroke volume during exercise in heart failure patients. Clin Sci (Lond) 2000; 98:545-551. (Pubitemid 30261003)
31. Lipkin DP, Poole-Wilson PA. Measurement of cardiac output during exercise by the thermodilution and direct Fick techniques in patients with chronic congestive heart failure. Am J Cardiol 1985; 56:321-324. (Pubitemid 15045240)
32. Nakanishi N, Yoshioka T, Okano Y, Nishimura T. Continuous Fick cardiac output measurement during exercise by monitoring of mixed venous oxygen saturation and oxygen uptake. Chest 1993; 104:419-426. (Pubitemid 23229510)
33. Elkayam U, Wilson AF, Morrison J, Meltzer P, Davis J, Klosterman P, et al. Noninvasive measurement of cardiac output by a single breath constant expiratory technique. Thorax 1984; 39:107-113. (Pubitemid 14150168)
34. Zenger MR, Brenner M, Haruno M, Mahon D, Wilson AF. Measurement of cardiac output by automated single-breath technique, and comparison with thermodilution and Fick methods in patients with cardiac disease. Am J Cardiol 1993; 71:105-109. (Pubitemid 23025834)
35. Jones NL, Campbell EJ, McHardy GJ, Higgs BE, Clode M. The estimation of carbon dioxide pressure of mixed venous blood during exercise. Clin Sci 1967; 32:311-327.
36. van Herwaarden CL, Binkhorst RA, Fennis JF, van't Laar A. Reliability of the cardiac output measurement with the indirect Fick-principle for CO2 during exercise. Pflugers Arch 1980; 385:21-23.
37. Klausen K. Comparison of CO2 rebreathing and acetylene methods for cardiac output. J Appl Physiol 1965; 20:763-766.
38. Farhi LE, Nesarajah MS, Olszowka AJ, Metildi LA, Ellis AK. Cardiac output determination by simple one-step rebreathing technique. Respir Physiol 1976; 28:141-159.
39. Sramek BB. Thoracic electrical bioimpedance measurement of cardiac output. Crit Care Med 1994; 22:1337-1339. (Pubitemid 24244844)
40. Stok WJ, Baisch F, Hillebrecht A, Schulz H, Meyer M, Karemaker JM. Noninvasive cardiac output measurement by arterial pulse analysis compared with inert gas rebreathing. J Appl Physiol 1993; 74:2687-2693. (Pubitemid 23201292)
41. Sackner MA, Greeneltch D, Heiman MS, Epstein S, Atkins N. Diffusing capacity, membrane diffusing capacity, capillary blood volume, pulmonary tissue volume, and cardiac output measured by a rebreathing technique. Am Rev Respir Dis 1975; 111:157-165.
42. Stringer WW, Hansen JE, Wasserman K. Cardiac output estimated noninvasively from oxygen uptake during exercise. J Appl Physiol 1997; 82:908-912. (Pubitemid 27123273)
43. Cohn JN, Johnson GR, Shabetai R, Loeb H, Tristani F, Rector T, et al. Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure. The V-HeFT VA Cooperative Studies Group. Circulation 1993; 87:VI5-VI16.
44. Lang CC, Karlin P, Haythe J, Tsao L, Mancini DM. Ease of noninvasive measurement of cardiac output coupled with peak VO2 determination at rest and during exercise in patients with heart failure. Am J Cardiol 2007; 99:404-405. (Pubitemid 46149559)
45. Sullivan MJ, Knight JD, Higginbotham MB, Cobb FR. Relation between central and peripheral hemodynamics during exercise in patients with chronic heart failure. Muscle blood flow is reduced with maintenance of arterial perfusion pressure. Circulation 1989; 80:769-781.
46. Schlosshan D, Barker D, Pepper C, Williams G, Morley C, Tan LB. CRT improves the exercise capacity and functional reserve of the failing heart through enhancing the cardiac flow- and pressure-generating capacity. Eur J Heart Fail 2006; 8:515-521. (Pubitemid 44205504)
47. Krogh A, Lindhard J. Measurements of the flow of blood through the lungs of man. Skandinavisches Archiv fuer Physiologie 1912; 27:100-125.
48. Peyton PJ, Poustie SJ, Robinson GJ, Penny DJ, Thompson B. Noninvasive measurement of intrapulmonary shunt during inert gas rebreathing. Physiol Meas 2005; 26:309-316. (Pubitemid 41223673)
49. Reinhart ME, Hughes JR, Kung M, Abraham WM, Ahmed T, Eyre P, Wanner A. Determination of pulmonary blood flow by the rebreathing technique in airflow obstruction. Am Rev Respir Dis 1979; 120:533-540. (Pubitemid 10142590)
50. Friedman M, Wilkins SA Jr, Rothfeld AF, Bromberg PA. Effect of ventilation and perfusion imbalance on inert gas rebreathing variables. J Appl Physiol 1984; 56:364-369. (Pubitemid 14143692)
51. Kallay MC, Hyde RW, Smith RJ, Rothbard RL, Schreiner BF. Cardiac output by rebreathing in patients with cardiopulmonary diseases. J Appl Physiol 1987; 63:201-210. (Pubitemid 17107146)
52. Agostoni P, Cattadori G, Apostolo A, Contini M, Palermo P, Marenzi G, Wasserman K. Noninvasive measurement of cardiac output during exercise by inert gas rebreathing technique: a new tool for heart failure evaluation. J Am Coll Cardiol 2005; 46:1779-1781. (Pubitemid 41531639)
53. Lang CC, Karlin P, Haythe J, Lim TK, Mancini DM. Peak cardiac power output, measured noninvasively, is a powerful predictor of outcome in chronic heart failure. Circ Heart Fail 2009; 2:33-38.
54. Goda A, Lang CC, Williams P, Jones M, Farr MJ, Mancini DM. Usefulness of noninvasive measurement of cardiac output during sub-maximal exercise to predict outcome in patients with chronic heart failure. Am J Cardiol 2009; 104:1556-1560.
55. Saur J, Trinkmann F, Doesch C, Weissmann J, Hamm K, Schoenberg SO, et al. Noninvasive measurement of cardiac output during atrial fibrillation: comparison between cardiac magnetic resonance imaging and inert gas rebreathing. Cardiology 2010; 115:212-216.